{"symbol":"LLY","fiscalQuarter":"Q4-2013","reportDate":"2014-01-30","reportTime":"BMO","status":"reported","company":{"name":"Eli Lilly and Company","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/LLY/earnings/Q4-2013","postBrief":{"headline":"Eli Lilly Beats on EPS, Stock Down 1.19%","keyNumbers":[{"metric":"EPS","actual":"$0.74","expected":"N/A","surprise":"+0.82%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Unknown","keyQuotes":[],"summary":"No transcript is on record, and the analysis is based on numerical results only."},"guidanceChanges":{"summary":"No guidance data is available.","changes":[]},"whatItMeans":"Eli Lilly reported an EPS of $0.74, which was a slight beat, but the stock reacted negatively, declining by 1.19%. The lack of revenue data and management commentary may have contributed to investor uncertainty. Overall, the mixed results suggest cautious sentiment among investors.","metaDescription":"Eli Lilly (LLY) Q4 2013 earnings: EPS beat by 0.82%. Stock down 1.19%. Full breakdown."}}